{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:25:34Z","timestamp":1782969934189,"version":"3.54.5"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["BIOT"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Biofilm production is a key factor in the development of antibiotic\nresistance in multidrug-resistant Klebsiella pneumoniae (K. pneumoniae), a significant\ncontributor to healthcare-associated infections (HAIs). Kaempferol, a flavonoid, is\nwidely recognized for its ability to combat various microorganisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>Our goal is to assess the impact of kaempferol on K. pneumoniae biofilms by determining\nthe level of gene expression for the biofilm-forming genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Fifty K. pneumoniae isolates were studied. Different doses of kaempferol with\na concentration range of 0.04 to 100% in Luria Bertani broth (LB) medium were incubated\nat 37\u2103 for 24 h with forty-three K. pneumoniae strong and intermediate biofilm producers.\nThe minimum inhibitory concentration (MIC) of kaempferol was determined.\nMolecular detection of the biofilm-forming genes (mrkA, pgaA, wbbM, and wzm) was\nperformed on all isolates before and after kaempferol treatment at 0.5 x MIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Seven isolates out of 50 (14%) exhibited weak biofilm formation ability, 6 out\nof 50 (12%) were moderate producers, and 37 out of 50 (74%) were strong producers.\nThe MIC values of kaempferol for K. pneumoniae ranged from 50% to 6.25% (p =\n0.0003). The levels of expression of the studied genes were slightly decreased after\ntreatment compared with their corresponding values before treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Based on current knowledge, few research studies have investigated the impact\nof kaempferol on K. pneumoniae biofilms. Our results show that its effect on the\nbiofilms of this bacterium is moderate to weak. Further research is necessary to determine\npotential synergies with other treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118722083386487250804015300","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T10:00:16Z","timestamp":1755252016000},"page":"501-514","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Kaempferol against Biofilm Formation by Klebsiella pneumoniae Clinical Isolates"],"prefix":"10.2174","volume":"20","author":[{"given":"Radwa Hamdy","family":"Abd Allah","sequence":"first","affiliation":[{"name":"Microbiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-0448","authenticated-orcid":true,"given":"Safia","family":"Samir","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-3131","authenticated-orcid":true,"given":"Sami Mohamed","family":"Nasr","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt"},{"name":"School of Biotechnology, Badr University in Cairo, Badr City, Cairo, 11829, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0089-4836","authenticated-orcid":true,"given":"Mohamed Khaled","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Microbiology Department, Faculty of Science, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1102065","DOI":"10.3389\/fimmu.2023.1102065","volume":"14","author":"Zhang K.","year":"2023","unstructured":"Zhang K.; Wang S.; Yao D.; Aerobic and facultative anaerobic Klebsiella pneumoniae strains establish mutual competition and jointly promote Musca domestica development. Front Immunol  2023,14,1102065","journal-title":"Front Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.taap.2018.12.008","volume":"364","author":"Sun Z.","year":"2019","unstructured":"Sun Z.; Li Q.; Hou R.; Kaempferol-3-O-glucorhamnoside inhibits inflammatory responses via MAPK and NF-\u03baB pathways in vitro and in vivo. Toxicol Appl Pharmacol  2019,364(700),22-28","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1137947","DOI":"10.3389\/fcimb.2023.1137947","volume":"13","author":"Zhao A.","year":"2023","unstructured":"Zhao A.; Sun J.; Liu Y.; Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol  2023,13,1137947","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12941-023-00632-9","volume":"22","author":"Attalla E.T.","year":"2023","unstructured":"Attalla E.T.; Khalil A.M.; Zakaria A.S.; Baker D.J.; Mohamed N.M.; Genomic characterization of colistin-resistant Klebsiella pneumoniae isolated from intensive care unit patients in Egypt. Ann Clin Microbiol Antimicrob  2023,22(1),82","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1238482","DOI":"10.3389\/fmicb.2023.1238482","volume":"14","author":"Li Y.","year":"2023","unstructured":"Li Y.; Ni M.; Regulation of biofilm formation in Klebsiella pneumoniae. Front Microbiol  2023,14,1238482","journal-title":"Front Microbiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.22092\/ARI.2022.357626.2076","volume":"77","author":"Makhrmash J.H.","year":"2022","unstructured":"Makhrmash J.H.; Al-Aidy S.R.; Qaddoori B.H.; Investigation of biofilm virulence genes prevalence in Klebsiella pneumoniae isolated from the urinary tract infections. Arch Razi Inst  2022,77(4),1421-1427","journal-title":"Arch Razi Inst"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.micpath.2014.11.005","volume":"77","author":"Chen K.M.","year":"2014","unstructured":"Chen K.M.; Chiang M.K.; Wang M.; Ho H.C.; Lu M.C.; Lai Y.C.; The role of pgaC in Klebsiella pneumoniae virulence and biofilm formation. Microb Pathog  2014,77,89-99","journal-title":"Microb Pathog"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/microorganisms10061239","volume":"10","author":"Sionov R.V.","year":"2022","unstructured":"Sionov R.V.; Steinberg D.; Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria. Microorganisms  2022,10(6),1239","journal-title":"Microorganisms"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.3389\/fmicb.2017.02263","volume":"8","author":"Ming D.","year":"2017","unstructured":"Ming D.; Wang D.; Cao F.; Kaempferol inhibits the primary attachment phase of biofilm formation in Staphylococcus aureus. Front Microbiol  2017,8,2263","journal-title":"Front Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"105058","DOI":"10.1016\/j.micinf.2022.105058","volume":"25","author":"Xu L.","year":"2023","unstructured":"Xu L.; Fang J.; Ou D.; Therapeutic potential of kaempferol on Streptococcus pneumoniae infection. Microbes Infect  2023,25(3),105058","journal-title":"Microbes Infect"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.3390\/ijms232315054","volume":"23","author":"Periferakis A.","year":"2022","unstructured":"Periferakis A.; Periferakis K.; Badarau I.A.; Kaempferol: Antimicrobial properties, sources, clinical, and traditional applications. Int J Mol Sci  2022,23(23),15054","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/molecules25225243","volume":"25","author":"Ullah A.","year":"2020","unstructured":"Ullah A.; Munir S.; Badshah S.L.; Important flavonoids and their role as a therapeutic agent. Molecules  2020,25(22),5243","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"Kang H.","year":"2021","unstructured":"Kang H.; Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof  2021,18,17","journal-title":"J Educ Eval Health Prof"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/aem.36.3.536-538.1978","volume":"36","author":"Bagley S.T.","year":"1978","unstructured":"Bagley S.T.; Seidler R.J.; Primary Klebsiella identification with MacConkey-inositol-carbenicillin agar. Appl Environ Microbiol  1978,36(3),536-538","journal-title":"Appl Environ Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e01864","DOI":"10.1128\/JCM.01864-19","volume":"58","author":"Weinstein M.P.","year":"2020","unstructured":"Weinstein M.P.; Lewis J.S.; The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: Background, organization, functions, and processes. J Clin Microbiol  2020,58(3),e01864-e19","journal-title":"J Clin Microbiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/jgid.jgid_150_19","volume":"12","author":"Shenoy V.P.","year":"2020","unstructured":"Shenoy V.P.; Harika K.; Narasimhaswamy N.; Chawla K.; Detection of biofilm production and its impact on antibiotic resistance profile of bacterial isolates from chronic wound infections. J Glob Infect Dis  2020,12(3),129-134","journal-title":"J Glob Infect Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biology13020078","volume":"13","author":"Abbas R.","year":"2024","unstructured":"Abbas R.; Chakkour M.; Zein El Dine H.; General overview of Klebsiella pneumonia : Epidemiology and the role of siderophores in its pathogenicity. Biology  2024,13(2),78","journal-title":"Biology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/pathogens10020165","volume":"10","author":"Kowalska-Krochmal B.","year":"2021","unstructured":"Kowalska-Krochmal B.; Dudek-Wicher R.; The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens  2021,10(2),165","journal-title":"Pathogens"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ja.2015.51","volume":"68","author":"Wu G.","year":"2015","unstructured":"Wu G.; Yang Q.; Long M.; Evaluation of agar dilution and broth microdilution methods to determine the disinfectant susceptibility. J Antibiot  2015,68(11),661-665","journal-title":"J Antibiot"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/26415275.2020.1796674","volume":"7","author":"Parvekar P.","year":"2020","unstructured":"Parvekar P.; Palaskar J.; Metgud S.; Maria R.; Dutta S.; The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus. Biomater Investig Dent  2020,7(1),105-109","journal-title":"Biomater Investig Dent"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"107399","DOI":"10.1016\/j.micpath.2025.107399","volume":"202","author":"Shah A.A.","year":"2025","unstructured":"Shah A.A.; Alwashmi A.S.S.; Abalkhail A.; Alkahtani A.M.; Emerging challenges in Klebsiella pneumoniae: Antimicrobial resistance and novel approach. Microb Pathog  2025,202,107399","journal-title":"Microb Pathog"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.24425\/cpe.2022.140833","volume":"43","author":"Konopacki M.","year":"2022","unstructured":"Konopacki M.; Augustyniak A.; Grygorcewicz B.; Do\u0142\u0119gowska B.; Kordas M.; Rakoczy R.; Growth optimization of Klebsiella pneumoniae in magnetically assisted bioreactor. Chem Process Eng  2022,43(3),289-304","journal-title":"Chem Process Eng"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1872208314666201112105053","volume":"15","author":"Saber M.A.","year":"2021","unstructured":"Saber M.A.; Okasha H.; Khorshed F.; Samir S.; A novel cell-based in vitro assay for antiviral activity of interferons \u03b1, \u03b2, and \u03b3 by qPCR of MxA gene expression. Recent Pat Biotechnol  2021,15(1),67-75","journal-title":"Recent Pat Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.2147\/IDR.S335582","volume":"14","author":"El-Far A.","year":"2021","unstructured":"El-Far A.; Samir S.; El-Gebaly E.; High rates of aminoglycoside methyltransferases associated with metallo-beta-lactamases in multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt. Infect Drug Resist  2021,14,4849-4858","journal-title":"Infect Drug Resist"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.meegid.2021.104722","volume":"89","author":"El-Far A.","year":"2021","unstructured":"El-Far A.; Samir S.; El-Gebaly E.; Assessment of eugenol inhibitory effect on biofilm formation and biofilm gene expression in methicillin resistant Staphylococcus aureus clinical isolates in Egypt. Infect Genet Evol  2021,89,104722","journal-title":"Infect Genet Evol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8472395","volume":"2020","author":"Diriba K.","year":"2020","unstructured":"Diriba K.; Kassa T.; Alemu Y.; Bekele S.; In vitro biofilm formation and antibiotic susceptibility patterns of bacteria from suspected external eye infected patients attending ophthalmology clinic, Southwest Ethiopia. Int J Microbiol  2020,2020,1-12","journal-title":"Int J Microbiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5751785","volume":"2016","author":"Abdel-Maksoud M.","year":"2016","unstructured":"Abdel-Maksoud M.; El-Shokry M.; Ismail G.; Methicillin-resistant Staphylococcus aureus recovered from healthcare- and community-associated infections in Egypt. Int J Bacteriol  2016,2016,1-5","journal-title":"Int J Bacteriol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13102818.2017.1281761","volume":"31","author":"Al-Shabib N.A.","year":"2017","unstructured":"Al-Shabib N.A.; Husain F.M.; Ahmad I.; Baig M.H.; Eugenol inhibits quorum sensing and biofilm of toxigenic MRSA strains isolated from food handlers employed in Saudi Arabia. Biotechnol Biotechnol Equip  2017,31(2),387-396","journal-title":"Biotechnol Biotechnol Equip"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e0119564","DOI":"10.1371\/journal.pone.0119564","volume":"10","author":"Yadav M.K.","year":"2015","unstructured":"Yadav M.K.; Chae S.W.; Im G.J.; Chung J.W.; Song J.J.; Eugenol: A phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms. PLoS One  2015,10(3),e0119564","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ddc3010011","volume":"3","author":"Chaachouay N.","year":"2024","unstructured":"Chaachouay N.; Zidane L.; Plant-derived natural products: A source for drug discovery and development. Drugs Drug Candid  2024,3(1),184-207","journal-title":"Drugs Drug Candid"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"16299","DOI":"10.3390\/ijms242216299","volume":"24","author":"Periferakis A.","year":"2023","unstructured":"Periferakis A.; Periferakis A.T.; Troumpata L.; Kaempferol: A review of current evidence of its antiviral potential. Int J Mol Sci  2023,24(22),16299","journal-title":"Int J Mol Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/molecules29092007","volume":"29","author":"Alrumaihi F.","year":"2024","unstructured":"Alrumaihi F.; Almatroodi S.A.; Alharbi H.O.A.; Pharmacological potential of kaempferol, a flavonoid in the management of pathogenesis via modulation of inflammation and other biological activities. Molecules  2024,29(9),2007","journal-title":"Molecules"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1515\/znc-2006-9-1003","volume":"61","author":"\u00d6z\u00e7elik B.","year":"2006","unstructured":"\u00d6z\u00e7elik B.; Orhan I.; Toker G.; Antiviral and antimicrobial assessment of some selected flavonoids. Z Naturforsch C J Biosci  2006,61(9-10),632-638","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"Effah C.Y.","year":"2020","unstructured":"Effah C.Y.; Sun T.; Liu S.; Wu Y.; Klebsiella pneumoniae: An increasing threat to public health. Ann Clin Microbiol Antimicrob  2020,19(1),1-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=35","author":"Erickson S","year":"2023","unstructured":"Erickson S; Gil J; Brown M; Methods for diagnosing and treating biofilm-related infections. Patent CN116507916A  2023","journal-title":"Patent CN116507916A"}],"container-title":["Recent Patents on Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118722083386487250804015300","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244539\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118722083386487250804015300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:11:30Z","timestamp":1782965490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244539\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118722083386487250804015300","relation":{},"ISSN":["1872-2083"],"issn-type":[{"value":"1872-2083","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}